Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug505 | Background questionnaire Wiki | 1.00 |
| drug1019 | Confinement and Communication During the COVID-19 Pandemic Wiki | 1.00 |
| drug3033 | Post Traumatic Stress Disorder questionnaire (PTSD-8) Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug598 | Blood donation from convalescent donor Wiki | 1.00 |
| drug1634 | Generalized Anxiety Disorder-7 (GAD 7) Wiki | 1.00 |
| drug1449 | Experiences in Close Relationship Scale questionnaire (ECR-S) Wiki | 1.00 |
| drug2830 | Patient Health Questionnaire (PHQ-9) Wiki | 1.00 |
| drug1909 | Impact of COVID-19 questionnaire Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D040921 | Stress Disorders, Traumatic NIH | 0.18 |
| D001008 | Anxiety Disorders NIH | 0.14 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The aim of this project is to evaluate the impact of pandemic and nonconfinement related to anxiety and eventual immune diseases with several standardized questionnaires : Implant Stability Quotient (ISQ) , Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire -9 (PHQ-9), Post Traumatic Stress Disorder-8 (PTSD-8), and Experiences in Close Relationship Scale (ECRS).
Description: test that will evaluate persistent and excessive worry about a number of different things. People with Generalized Anxiety Disorder may anticipate disaster and may be overly concerned about money, health, family, work, or other issues. Individuals with Generalized Anxiety Disorder find it difficult to control their worry. Scored between 0-21: Cut offs: 0-4 = None 5-9 = Mild anxiety 10-14 = Moderate anxiety 15-21 = Severe anxiety
Measure: Results of the Generalized Anxiety Disorder (GAD-7) Time: 5 MinutesDescription: Welfare effect (mental health positively or negatively affected by COVID-19; why?) Scored between 7-42. These are treated as continuous variables.
Measure: Results of the Mental Health questionnaire Time: 5 minutesDescription: assess depression during the pandemic Scored between 0-27: Cut offs: 0-4 = None 5-9 = Mild depression 10-14 = Moderate depression 15-19 = Moderately severe depression 20-27 = Severe depression
Measure: Results of the Patient Health Questionnaire (PHQ-9) Time: 5 minutesDescription: Assessing the trauma of subjects during the pandemic Scored between 7-42. These are treated as continuous variables.
Measure: Results of the Post Traumatic Stress Disorder (PTSD-8) Time: 5 minutesDescription: Measuring social ties and attachment of subjects Scored between 7-42. These are treated as continuous variables.
Measure: Results of the Experiences in Close Relationship Scale questionnaire (ECR-S) Time: 5 minutesAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports